1. Home
  2. USAS vs IMTX Comparison

USAS vs IMTX Comparison

Compare USAS & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

HOLD

Current Price

$3.96

Market Cap

1.5B

ML Signal

HOLD

Logo Immatics N.V.

IMTX

Immatics N.V.

HOLD

Current Price

$9.12

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USAS
IMTX
Founded
1998
N/A
Country
Canada
Germany
Employees
N/A
407
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
USAS
IMTX
Price
$3.96
$9.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$6.50
$19.00
AVG Volume (30 Days)
3.6M
325.4K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$174.68
N/A
Revenue Next Year
$53.17
$25.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$5.05
52 Week High
$10.50
$12.41

Technical Indicators

Market Signals
Indicator
USAS
IMTX
Relative Strength Index (RSI) 38.94 40.53
Support Level $3.53 $8.99
Resistance Level $4.37 $10.67
Average True Range (ATR) 0.26 0.46
MACD 0.03 -0.03
Stochastic Oscillator 34.38 5.04

Price Performance

Historical Comparison
USAS
IMTX

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: